South Dakota Investment Council increased its position in Eastman Chemical Company (NYSE:EMN - Free Report) by 10.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 83,138 shares of the basic materials company's stock after buying an additional 7,700 shares during the quarter. South Dakota Investment Council owned 0.07% of Eastman Chemical worth $7,325,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds also recently made changes to their positions in the company. Beverly Hills Private Wealth LLC increased its position in Eastman Chemical by 4.5% during the 1st quarter. Beverly Hills Private Wealth LLC now owns 3,304 shares of the basic materials company's stock valued at $291,000 after purchasing an additional 143 shares during the period. Prudent Man Advisors LLC increased its position in Eastman Chemical by 2.2% during the 1st quarter. Prudent Man Advisors LLC now owns 6,651 shares of the basic materials company's stock valued at $586,000 after purchasing an additional 144 shares during the period. Roman Butler Fullerton & Co. increased its position in Eastman Chemical by 6.1% during the 1st quarter. Roman Butler Fullerton & Co. now owns 2,864 shares of the basic materials company's stock valued at $252,000 after purchasing an additional 164 shares during the period. Goelzer Investment Management Inc. increased its position in Eastman Chemical by 0.5% during the 1st quarter. Goelzer Investment Management Inc. now owns 36,505 shares of the basic materials company's stock valued at $3,216,000 after purchasing an additional 164 shares during the period. Finally, TD Private Client Wealth LLC increased its position in Eastman Chemical by 46.4% during the 1st quarter. TD Private Client Wealth LLC now owns 536 shares of the basic materials company's stock valued at $47,000 after purchasing an additional 170 shares during the period. 83.65% of the stock is owned by hedge funds and other institutional investors.
Eastman Chemical Price Performance
Shares of NYSE:EMN opened at $77.74 on Friday. The firm's 50 day moving average price is $79.08 and its 200-day moving average price is $85.51. Eastman Chemical Company has a twelve month low of $70.90 and a twelve month high of $114.50. The company has a quick ratio of 0.79, a current ratio of 1.72 and a debt-to-equity ratio of 0.80. The stock has a market capitalization of $8.98 billion, a PE ratio of 9.89, a price-to-earnings-growth ratio of 1.87 and a beta of 1.22.
Eastman Chemical (NYSE:EMN - Get Free Report) last announced its quarterly earnings data on Thursday, April 24th. The basic materials company reported $1.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.89 by $0.02. Eastman Chemical had a net margin of 9.85% and a return on equity of 16.59%. The business had revenue of $2.29 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same period last year, the firm posted $1.61 EPS. The company's revenue was down .9% on a year-over-year basis. Equities research analysts expect that Eastman Chemical Company will post 8.55 EPS for the current year.
Eastman Chemical Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, July 8th. Investors of record on Friday, June 13th were issued a $0.83 dividend. The ex-dividend date of this dividend was Friday, June 13th. This represents a $3.32 annualized dividend and a dividend yield of 4.27%. Eastman Chemical's payout ratio is currently 42.24%.
Analyst Upgrades and Downgrades
A number of research firms have recently weighed in on EMN. Piper Sandler reduced their target price on shares of Eastman Chemical from $105.00 to $99.00 and set a "neutral" rating on the stock in a research report on Monday, April 7th. Citigroup raised shares of Eastman Chemical from a "neutral" rating to a "buy" rating and reduced their target price for the stock from $105.00 to $101.00 in a research report on Friday, April 4th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $76.00 target price (down from $112.00) on shares of Eastman Chemical in a research report on Monday, April 28th. Morgan Stanley reduced their target price on shares of Eastman Chemical from $125.00 to $115.00 and set an "overweight" rating on the stock in a research report on Monday, April 28th. Finally, UBS Group reduced their target price on shares of Eastman Chemical from $107.00 to $101.00 and set a "buy" rating on the stock in a research report on Wednesday, July 9th. Six analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $97.08.
Check Out Our Latest Stock Report on EMN
Eastman Chemical Company Profile
(
Free Report)
Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Eastman Chemical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eastman Chemical wasn't on the list.
While Eastman Chemical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.